The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124160232 12416023 2 F 2016 20160719 20160530 20160725 EXP US-UCBSA-2016012348 UCB 0.00 F Y 45.00000 KG 20160725 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124160232 12416023 1 PS CIMZIA CERTOLIZUMAB PEGOL 1 Subcutaneous 400 MG, EV 2 WEEKS(QOW) U 125160 400 MG SOLUTION FOR INJECTION QOW
124160232 12416023 2 SS CIMZIA CERTOLIZUMAB PEGOL 1 Subcutaneous 200 MG, EV 2 WEEKS(QOW) U 125160 200 MG SOLUTION FOR INJECTION QOW
124160232 12416023 3 C CELEBREX CELECOXIB 1 Oral 2 DF, ONCE DAILY (QD) U U 0 2 DF CAPSULE QD
124160232 12416023 4 C PREMARIN ESTROGENS, CONJUGATED 1 Oral 0.625MG TABLET 1 ONCE DAILY EXCEPT END OF THE MONTH - NO TABLETS FOR 5 DAYS; POST-MENOPAUSE; U U 0 TABLET
124160232 12416023 5 C ATENOLOL. ATENOLOL 1 Oral 25 MG, ONCE DAILY (QD) U U 0 25 MG TABLET QD
124160232 12416023 6 C Hyaluronic acid HYALURONIC ACID 1 Oral 2 DF, ONCE DAILY (QD) U U 0 2 DF TABLET QD
124160232 12416023 7 C Hyaluronic acid HYALURONIC ACID 1 Oral 1 DF, ONCE DAILY (QD) U U 0 1 DF TABLET QD
124160232 12416023 8 C Multivitamin VITAMINS 1 Oral 1 DF, ONCE DAILY (QD) U U 0 1 DF TABLET QD
124160232 12416023 9 C Calcium CALCIUM 1 U U 0
124160232 12416023 10 C VITAMIN D CHOLECALCIFEROL 1 U U 0
124160232 12416023 11 C PREDNISONE. PREDNISONE 1 Oral 1 DF, ONCE DAILY (QD) U 0 1 DF TABLET QD
124160232 12416023 12 C HYDROCORTISONE. HYDROCORTISONE 1 UNK U 0
124160232 12416023 13 C Triamcinolone TRIAMCINOLONE 1 UNK U 0 CREAM

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124160232 12416023 1 Rheumatoid arthritis
124160232 12416023 2 Psoriatic arthropathy
124160232 12416023 3 Rheumatoid arthritis
124160232 12416023 4 Postmenopause
124160232 12416023 5 Hypertension
124160232 12416023 6 Product used for unknown indication
124160232 12416023 8 Product used for unknown indication
124160232 12416023 9 Product used for unknown indication
124160232 12416023 10 Product used for unknown indication
124160232 12416023 11 Rheumatoid arthritis
124160232 12416023 12 Product used for unknown indication
124160232 12416023 13 Eczema

Outcome of event

Event ID CASEID OUTC COD
124160232 12416023 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
124160232 12416023 Acne
124160232 12416023 Eczema
124160232 12416023 Fatigue
124160232 12416023 Headache
124160232 12416023 Pruritus
124160232 12416023 Rotator cuff syndrome
124160232 12416023 Sinus disorder

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124160232 12416023 1 20160421 2016 0
124160232 12416023 2 2016 0
124160232 12416023 12 20160401 0
124160232 12416023 13 2016 0